The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
(<i>L</i>-)tryptophan is metabolized via the kynurenine pathway into several kynurenine metabolites with distinct functions. Dysfunction of the kynurenine pathway can lead to impairments in vascular regulation, immune regulation, and tolerance. The first and rate limiting enzyme of this...
Guardado en:
Autores principales: | Michelle Broekhuizen, A. H. Jan Danser, Irwin K. M. Reiss, Daphne Merkus |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2520dc31aab497e8e697138f930e1ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
por: V. A. Kozlov, et al.
Publicado: (2017) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Corina Bello, et al.
Publicado: (2021) -
Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway
por: Jeong Hun Kim, et al.
Publicado: (2021) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Ilona Sadok, et al.
Publicado: (2021)